Calamos Advisors LLC acquired a new position in Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 375,000 shares of the company’s stock, valued at approximately $6,915,000.
Separately, Tuttle Capital Management LLC acquired a new position in shares of Translational Development Acquisition during the fourth quarter valued at $461,000.
Translational Development Acquisition Stock Up 0.1 %
Shares of TDACU opened at $10.06 on Wednesday. Translational Development Acquisition Corp. has a 52-week low of $10.00 and a 52-week high of $10.06.
About Translational Development Acquisition
Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.
Featured Stories
- Five stocks we like better than Translational Development Acquisition
- Options Trading – Understanding Strike Price
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Technology Stocks Explained: Here’s What to Know About Tech
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report).
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
